Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46K Sell
251
-2
-0.8% -$369 0.04% 187
2025
Q4
$44.5K Hold
253
0.03% 203
2025
Q3
$35.4K Hold
253
0.02% 233
2025
Q2
$31.8K Buy
+253
New +$31.5K 0.02% 243
2024
Q3
$64.2K Sell
331
-2
-0.6% -$418 0.05% 165
2024
Q2
$77.2K Buy
+333
New +$72.4K 0.07% 143
2023
Q3
$111K Hold
433
0.12% 106
2023
Q2
$123K Buy
+433
New +$129K 0.12% 100
2023
Q1
Sell
-442
Closed -$122K 100
2022
Q4
$122K Buy
+442
New +$125K 0.09% 121
2022
Q3
Sell
-442
Closed -$90K 114
2022
Q2
$90K Buy
+442
New +$90.4K 0.08% 123
2022
Q1
Sell
-442
Closed -$106K 95
2021
Q4
$106K Hold
442
0.06% 162
2021
Q3
$125K Buy
+442
New +$145K 0.09% 126
2021
Q1
Sell
-567
Closed -$244 96
2020
Q4
$244 Buy
+567
New +$146K 0.06% 36

Other funds holding BIIB

WFA of San Diego's BIIB Position: Q1 2026 in Review

WFA of San Diego reduced its Biogen (BIIB) stake by 0.79% in Q1 2026, selling an estimated $369 and leaving 251 shares worth $46K. The position accounts for 0.04% of the portfolio, ranked #187.

WFA of San Diego first reported a position in BIIB in Q4 2020 and has held it in 13 quarters since. The position peaked at $125K in Q3 2021. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • WFA of San Diego held 251 shares of Biogen worth $46K as of Q1 2026.
  • WFA of San Diego sold 2 Biogen shares in Q1 2026, an estimated $369.
  • Biogen made up 0.04% of WFA of San Diego's portfolio in Q1 2026, its #187 holding.
  • WFA of San Diego first reported a position in Biogen in Q4 2020 and has held it in 13 quarters since.
  • WFA of San Diego's Biogen position peaked at $125K in Q3 2021.
  • 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on WFA of San Diego's 13F filing for Q1 2026, filed 11 May 2026.